Abstract:Objective To explore the effect of ketogenic diet (KD) on β-cell dedifferentiation and hepatic lipid accumulation in db/db mice. Methods After a 3-week habituation, male db/db mice aged 8 weeks were assigned into normal diet (ND) group, KD group and 75% calorie restriction (CR) group, with free access to standard diet, KD and 75% of standard diet, respectively. In addition, sex-matched 8-week-old C57BL/6 mice were used to construct a control (C) group. After a 4-week dietary intervention, mouse body weight, fasting blood glucose (FBG), blood lipids, fasting insulin (FINS), glucose tolerance and β-hydroxybutyric acid level were measured. The morphologies of islet and liver were observed by H&E staining. Positive expressions of β-cell specific transcription factors in mouse islets were determined by double immunofluorescence staining. The size and number of lipid droplets in mouse liver were examined by oil red O staining. Relative levels of adipogenesis-associated and lipolysis-associated genes in mouse liver were detected by qRT-PCR. In addition, expressions of CD36 protein in the mouse liver were determined by immunohistochemical staining and Western blot. Results After a 4-week dietary intervention, FBG, FINS and glucose area under the curve in KD group became significantly lower than those in ND group (all P <0.05). A regular morphology of mouse islet was observed in KD group, with an increased number of islet cells. KD significantly reversed the decrease in β-cell number, disarrangement of β-cells, decline of β/α-cell ratio and downregulation of β-cell specific transcription factors in db/db mice. Serum levels of triglyceride, total cholesterol and low-density lipoprotein cholesterol were comparable between ND and KD groups, while serum triglyceride level was significantly lower in CR group than in ND group ( P <0.05). Vacuolar degeneration and lipid accumulation in the liver were more prominent in KD group than in ND and CR groups. The mRNA levels of P parα and A cox1 in KD group were lower than those in ND group, although no significant differences were detected. Relative levels of C d36 and inflammatory genes in the mouse liver were significantly higher in KD group than in ND group (all P <0.05). Conclusion KD significantly reduces FBG and FINS, and improves glucose tolerance in db/db mice by upregulating β-cell specific transcription factors and reversing β-cell dedifferentiation. However, KD also induces hepatic lipid accumulation and aggravates inflammatory response in the liver of db/db mice.

Effect of Rimonabant on Improvement of Glucose and Lipid Metabolism and CB1 Receptor Expression in Peripheral Tissues in KKAy Mice

Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways

Lose-weight effect to high fat diet-induced obese mice of an analogue of rimonabant

A Novel Traditional Chinese Medicine, Ramulus Mori (Sangzhi) Alkaloids Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice

Interleukin-1 Receptor Antagonist Improves Normoglycemia and Insulin Sensitivity in Diabetic Goto-Kakizaki-Rats

Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism

Ginsenoside Rb1 Improves Metabolic Disorder in High-Fat Diet-Induced Obese Mice Associated With Modulation of Gut Microbiota

Study on the effecto f Xuezhikang on pancreatici slet endocrine function via glucose-sensing apparatus in db/db mice

Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study

New peripherally-restricted CB1 receptor antagonists, PMG-505-010 and -013 ameliorate obesity-associated NAFLD and fibrosis

A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice

Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice

Ketogenic diet alleviates β-cell dedifferentiation but aggravates hepatic lipid accumulation in db/db mice

Raspberry ketone and Garcinia Cambogia rebalanced disrupted insulin resistance and leptin signaling in rats fed high fat fructose diet

Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice

Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice

Effects of Rebaudioside A on the Β Cell Function and Lipid Metabolism in Rats Fed High-Fat Diets

Effect of Ezetimibe on Insulin Secretion in Db/db Diabetic Mice

Beneficial Effects of Ezetimibe on Secretory Function of β-cell in db/db Mice

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice